-
admin
Posts
China Telecom, HONOR and Bosch for a ubiquitous connectivity all-elements network quality assurance solution
HONG KONG, Dec. 24, 2024 /PRNewswire/ — China Telecom’s Open Gateway API serves as a ubiquitous connection and a full-scenario solution, which is widely applied...
GDIN Successfully Supports Establishment of 10 New Joint Ventures in 2024 Alone
GDIN CEO Jongkap Kim: “By matching technology needs with local markets, we create long-lasting joint ventures with multiple exit opportunities.” SEOUL, South Korea, Dec. 24,...
Elastomer Gel in Personal Care Market Expected to Grow at 4.1% CAGR To Reach USD 238.91 Million by 2034 | PMR
The growing need for high-performing, cutting-edge ingredients in skincare, haircare, and cosmetic products has been fueling the market for elastomer gel in personal care products....
India Jewelry Market Report 2024-2029: India’s Religious Beliefs, Traditions, and Festive Culture Boosts Demand, Particularly Gold
The market is concentrated, with leading players in the organized sector capturing over 30% of total market sales and nearly 90% of the share within...
Immunocore announces first patient dosed in the Phase 1 trial of IMC-P115C, a half-life extended (HLE) ImmTAC candidate in patients with tumors that express PRAME
Immunocore announces first patient dosed in the Phase 1 trial of IMC-P115C, a half-life extended (HLE) ImmTAC candidate in patients with tumors that express PRAME...
SeaStar Medical Activates 14th Hospital for its Adult AKI Pivotal Trial
DENVER, Dec. 23, 2024 (GLOBE NEWSWIRE) — SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences...
Helius Announces First Portable Neuromodulation Stimulator (PoNS®) System Sale to the Veterans Affairs (VA) Healthcare System
Initial order placed with Company’s distributor at contracted price and represents operational implementation through VA Federal Supply Schedule (FSS) Contract NEWTOWN, Pa., Dec. 23, 2024...
Blarcamesine Receives EMA Filing Acceptance for Treatment of Alzheimer’s Disease
Blarcamesine: Potential novel oral treatment to target upstream Alzheimer’s disease pathology through autophagy enhancement Submission based on favorable ANAVEX®2-73-AD-004 trial results in patients with early...
TScan Therapeutics Refinances Existing Convertible Debt Facility with Term Loan for up to $52.5 Million from Silicon Valley Bank
New non-dilutive structure replaces existing convertible facility maturing in 2026, and extends loan maturity to 2029 WALTHAM, Mass., Dec. 23, 2024 (GLOBE NEWSWIRE) — TScan...
Designing for the future: SM’s vision through an architect’s lens
PASAY CITY, Philippines, Dec. 23, 2024 /PRNewswire/ — The SM Group, through its integrated property developer arm, SM Prime Holdings, Inc., is setting a benchmark...
